Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Farmers Insurance
US Department of Justice
Federal Trade Commission

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,008,228

« Back to Dashboard

Summary for Patent: 6,008,228

Title: Pharmaceutical compositions containing proteinase inhibitors
Abstract:Compositions which increase the bioavailability of proteinase inhibitors are disclosed. Compositions which include a pharmaceutically acceptable carrier comprising monoglycerides of medium chain-fatty acids are preferred. Preferred medium chain fatty acid glycerides include monoglycerides of saturated C.sub.6 to C.sub.12 fatty acids, preferably C.sub.8 to C.sub.10 fatty acids The pharmaceutically acceptable carrier preferably has an acid value of less than or equal to about 2.5. Preferably, the ratio of monoglycerides of medium chain fatty acid to the proteinase inhibitor is about at least 1.5.
Inventor(s): Bailey; Carole Anne (Warren, NJ), Ferdinando; Josephine Christine (Chippenham, GB), Shah; Navnit (Clifton, NJ)
Assignee: Hoffman-La Roche Inc. (Nutley, NJ)
Application Number:08/616,233
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;

No matches for this query

International Patent Family for Patent: 6,008,228

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China1092960► Subscribe
China1186434► Subscribe
Colombia4700448► Subscribe
Cyprus2373► Subscribe
Czech Republic9703803► Subscribe
Czech Republic292192► Subscribe
Germany69624354► Subscribe
Denmark0831826► Subscribe
Eurasian Patent Organization001413► Subscribe
Egypt24294► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Chinese Patent Office
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus